People with relapsing-remitting multiple sclerosis (RRMS) who show even a single silent lesion on an MRI scan while taking a lower- or moderate-efficacy disease-modifying therapy (DMT) may benefit from switching to a higher-efficacy treatment, according to a large international study. Researchers found that having one or more silent…
Discussion
I’m drowning. Well, not literally. I’ve never even come close to actually drowning — not even with last year’s pneumonia and the occasional aspiration of liquids. I’m just using it as a metaphor because it seems fitting and I know how much everyone likes metaphors. It may be a…
Discussion
Certain cannabis-based therapies may provide relief from spasticity in people with multiple sclerosis (MS), according to a review of data from 27 clinical trials involving more than 3,000 participants. Among the different therapies evaluated, those containing an equal mix of two of the main compounds found in the cannabis…
Discussion
In people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with poorer cognitive function, while higher levels of formal education are linked to better cognitive performance, a new study found. The findings highlight the relationship between physical and cognitive symptoms of MS, even among people with mild…
Discussion
Following the submission of thousands of pages of documentation, the U.S. Food and Drug Administration (FDA) has given the green light for a mid-stage clinical trial of Lucid-MS, a potential first-in-class oral therapy for multiple sclerosis (MS). With the FDA’s clearance of an investigational new drug (IND) application from…
Get regular updates to your inbox.
